2024年10月08日

Pharma Law USA

分享

FDA Regulatory partner, George O’Brien will discuss “Hot Topics in Patents including Orange Book Cases & Patent Eligibility” on October 8 at this year’s Pharma Law USA conference in Boston presented by Informa. The panel will address:

  • Review of FTC’s notice for Orange Book patent violations
  • Cooperation between FTC, FDA and Patent and Trademark Office
  • How should patents be managed and granted?
  • Is there an alternate way to force more generic substitution?
  • Patent eligibility: lessons learnt from Regeneron Vs Kymab and Revised Patent Subject Matter Eligibility Guidance
  • FDA’s 30-month preliminary injunctions: can they result in anti-trust violations?

For more information and to register, please visit the event webpage.

相关服务及行业

及时掌握我们的最新见解

见证我们如何使用跨学科的综合方法来满足客户需求
[订阅]